GLP-1 Receptor Agonists and Cardiovascular Outcomes

GLP-1 Receptor Agonists and Cardiovascular Outcomes is organized by Preventive Cardiovascular Nurses Association (PCNA).

Course Overview
In this free pharmacology continuing education course, Eryn Bryant, RN, MS, ANP discusses the use of GLP-1 Receptor Agonists (GLP-1 RAs) in clinical practice. This CE course describes the cardiovascular and heart failure outcomes associated with this important hormone.

Learning Objectives
• Review the cardiovascular burden for people with type 2 diabetes.
• Describe the clinical efficacy and safety profile of GLP-1 Receptor Agonists (GLP-1 RAs)
• Interpret cardiovascular and heart failure outcomes associated with GLP-1 RAs.
• Demonstrate prudent use of GLP-1 RAs in clinical practice.

Additional details will be posted as soon as information is available.